Keynote lecture session 2021

25 February 2021

A PVRI 2024 Digital webinar

Presentations

Health and wearables: Is this the dawn of a new age for cardiovascular medicine? Martin Cowie
Professor Sheila Glennis Haworth Memorial Lecture - Translational Research on PAH, Jason Yuan
Biomarker Analysis of the PULSAR Study: An Ongoing Phase 2, Double-Blind, Placebo-Controlled, Randomized Study to Compare the Efficacy and Safety of Sotatercept (ACE-011) Versus Placebo When Added to Standard of Care for the Treatment of PAH, Marc Humbert
Switching from PDE5i to riociguat in patients with PAH: The REPLACE study, Raymond Benza
A diagnostic miRNA signature for PAH using a consensus machine learning approach (Rupert Swift Award 2021), Niamh Errington

Martin Cowie, Imperial College London, UK

Jason Yuan, University of California San Diego, USA

Marc Humbert, University of Paris-Saclay, France

Raymond Benza, The Ohio State University, USA

Niamh Errington, Imperial College London, UK

Other materials on this topic

5 August 2024

Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension

Various erythropoietic abnormalities are highly prevalent among patients with pulmonary arterial hypertension (PAH) and associated with worse disease severity. Given the poorly understood yet important roles of dysregulated erythropoiesis and iron metabolism in PAH, we sought to further characterize the hematologic and iron profiles in PAH and their relationship to PAH severity.

Pulmonary Circulation

12 June 2024

Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER-MRI studies

A blood test identifying patients at increased risk of pulmonary hypertension (PH) could streamline the investigative pathway...

Pulmonary Circulation

26 August 2021

The notch receptors: multi-regulators of PAH development

Role of notch1 in experimental pulmonary hypertension Ralph Schermuly
Notch-BMPR interactions in endothelium in PAH Marlene Rabinovitch
Notch3 is a driver and biomarker for PAH Patricia Thistlethwaite
Notch3 lineage and pulmonary vasculopathy Maya Kumar

PVRI Digital Webinar Series

Additional comments are available to members. Login or register to become a member today

RegisterorLogin to view